Terms: = Endocrine gland cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Treatment
162 results:
1. Understanding autoimmune pancreatitis: Clinical features, management challenges, and association with malignancies.
Christodoulidis G; Kouliou MN; Koumarelas KE
World J Gastroenterol; 2024 Apr; 30(15):2091-2095. PubMed ID: 38681985
[TBL] [Abstract] [Full Text] [Related]
2. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
4. Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian cancer.
Leman R; Muller E; Legros A; Goardon N; Chentli I; Atkinson A; Tranchant A; Castera L; Krieger S; Ricou A; Boulouard F; Joly F; Boucly R; Dumont A; Basset N; Coulet F; Chevalier LM; Rouleau E; Leitner K; González-Martin A; Gargiulo P; Lück HJ; Genestie C; ; Ray-Coquard I; Pujade-Lauraine E; Vaur D
Clin Cancer Res; 2023 Nov; 29(21):4419-4429. PubMed ID: 37756555
[TBL] [Abstract] [Full Text] [Related]
5. Radiation Therapy Changed the Second Malignancy Pattern in Rectal cancer Survivors.
Ye X; Tan Y; Ma R; Lou P; Yuan Y
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629753
[No Abstract] [Full Text] [Related]
6. Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.
Lin J; Huang H
Sci Rep; 2023 Aug; 13(1):12824. PubMed ID: 37550460
[TBL] [Abstract] [Full Text] [Related]
7. Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.
May T; Bernardini M; Lheureux S; Aben KKH; Bandera EV; Beckmann MW; Benitez J; Berchuck A; Bjørge L; Carney ME; Cramer DW; deFazio A; Dörk T; Eccles DM; Friedlander M; García MJ; Goode EL; Hein A; Høgdall CK; Jensen A; Johnatty S; Kennedy CJ; Kiemeney LA; Kjær SK; Kupryjańczyk J; Matsuo K; McGuire V; Modugno F; Paddock LE; Pejovic T; Phelan CM; Riggan MJ; Rodriguez-Antona C; Rothstein JH; Sieh W; Song H; Terry KL; van Altena AM; Vanderstichele A; Vergote I; Thomsen LCV; Webb PM; Wentzensen N; Wilkens LR; Ziogas A; Jiang H; Tone A;
Can J Surg; 2023; 66(3):E310-E320. PubMed ID: 37369443
[TBL] [Abstract] [Full Text] [Related]
8. Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation.
Zhang J; Song J; Tang S; Zhao Y; Wang L; Luo Y; Tang J; Ji Y; Wang X; Li T; Zhang H; Shao W; Sheng J; Liang T; Bai X
Cell Rep; 2023 Jun; 42(6):112620. PubMed ID: 37285267
[TBL] [Abstract] [Full Text] [Related]
9. Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review.
Willink CY; Jenniskens SFM; Klaassen NJM; Stommel MWJ; Nijsen JFW
BJS Open; 2023 May; 7(3):. PubMed ID: 37254902
[TBL] [Abstract] [Full Text] [Related]
10. IncRNA XIST Stimulates Papillary Thyroid cancer Development through the miR-330-3p/PDE5A Axis.
Cai T; He Y; Peng B
Crit Rev Eukaryot Gene Expr; 2023; 33(3):13-26. PubMed ID: 37017666
[TBL] [Abstract] [Full Text] [Related]
11. Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial.
Senkus E; Delaloge S; Domchek SM; Conte P; Im SA; Xu B; Armstrong A; Masuda N; Fielding A; Robson M; Tung N
Int J Cancer; 2023 Aug; 153(4):803-814. PubMed ID: 36971103
[TBL] [Abstract] [Full Text] [Related]
12. Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic cancer. Do They Matter?
Murimwa GZ; Karalis JD; Meier J; Yan J; Zhu H; Hester CA; Porembka MR; Wang SC; Mansour JC; Zeh HJ; Yopp AC; Polanco PM
Ann Surg Oncol; 2023 Jul; 30(7):4377-4387. PubMed ID: 36964844
[TBL] [Abstract] [Full Text] [Related]
13. Robotic Right Posterior Sectionectomy by Intrafascial Approach for Pancreas Neuroendocrine Liver Metastasis.
Saadoun JE; Vanbrugghe C; Fara R; Camerlo A
Ann Surg Oncol; 2023 Jul; 30(7):4276. PubMed ID: 36949294
[TBL] [Abstract] [Full Text] [Related]
14. [The expression and significance of protease activated receptor 2 in ovarian epithelial carcinoma].
Liu SH; Ma YM; Zhang YN; Zhao XH; Wang HY; Li B
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):64-73. PubMed ID: 36709122
[No Abstract] [Full Text] [Related]
15. [Validation of calculation method for dose distribution around radioactive iodine-125 particles based on AAPM TG43 report].
Tian SQ; Wang JJ; Ji Z; Jiang YL; Qiu B; Fan JH; Sun HT
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):199-204. PubMed ID: 36649991
[No Abstract] [Full Text] [Related]
16. Anticancer Benefit of Metformin in Patients With Early-Stage Pancreatic cancer: A Retrospective Cohort Study.
Chen Y; Qian FJ; Ye ZQ; Xie WX; He YD; Huang JR; Tian L; Gu DN
Technol Cancer Res Treat; 2022; 21():15330338221138208. PubMed ID: 36583563
[No Abstract] [Full Text] [Related]
17. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic cancer: A Propensity Score Matching Analysis.
Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
[TBL] [Abstract] [Full Text] [Related]
18. If the price is right: Cost-effectiveness of radiofrequency ablation versus thyroidectomy in the treatment of benign thyroid nodules.
Kuo EJ; Oh A; Hu Y; McManus CM; Lee JA; Kuo JH
Surgery; 2023 Jan; 173(1):201-206. PubMed ID: 36334980
[TBL] [Abstract] [Full Text] [Related]
19. Race, Affordability and Utilization of Supportive Care in Ovarian cancer Patients.
Anyanwu MC; Ohamadike O; Wilson LE; Meernik C; Huang B; Pisu M; Liang M; Previs RA; Joshi A; Ward KC; Tucker T; Schymura MJ; Berchuck A; Akinyemiju T
J Pain Symptom Manage; 2022 Dec; 64(6):537-545. PubMed ID: 36058401
[TBL] [Abstract] [Full Text] [Related]
20. [IL-1β inhibitor sensitizes to olaparib in homologous recombination deficiency proficient ovarian cancer cells].
Xu JF; Cen YX; Tang SS; Ren Y; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2022 Jul; 57(7):519-529. PubMed ID: 35902786
[No Abstract] [Full Text] [Related]
[Next]
